Business Wire

Vista Entertainment Solutions Announces Significant Signing of Filmhouse Cinemas in Nigeria

Share

Vista Entertainment Solutions (Vista Cinema), the leading provider of cinema management software for the global cinema exhibition market and the founding company of Vista Group International (NZX & ASX: VGL), is delighted to announce the signing of Filmhouse Cinemas in Nigeria.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171101005965/en/

Under the agreement, Filmhouse Cinemas will roll out Vista Cinema software across all ten of their cinema sites, comprising 43 screens in total, located throughout Nigeria. The project will commence immediately and is due to be completed by December 2017. Filmhouse Cinemas holds the largest cinema exhibition market share in Nigeria and operates the only IMAX site in West Africa.

Filmhouse Cinemas Group Deputy Managing Director Kene Okwuosa has expressed his delight with the partnership with Vista. “We are so happy to begin this new journey. Vista brings with its amazing team a whole new world of features that will only enhance our audiences’ cinematic experience. As Filmhouse continues to be innovative and pave the way as market leaders, the support of partners like Vista is vital to executing our strategies.”

Significantly, Nigeria is the world’s second largest market in terms of films produced; its total box office take in 2016 was USD$8.32 million, a record high for Nigeria.

Vista Cinema CEO Kimbal Riley says the agreement is very significant for Vista. “With the largest population of any African country, Nigeria is the continent’s fastest-growing cinema exhibition market, and partnering with Filmhouse is key to ensuring Vista is part of that.”

The new partnership with Filmhouse is a credit to London-based Vista Cinema EMEA Managing Director Mischa Kay and his team. “We have recently established Vista South Africa in light of the growth of cinema exhibition in the region. This new agreement is a fantastic opportunity to partner with a dynamic and ambitious company and reminds us of the importance of that commitment; Filmhouse is exploiting the opportunities offered by Nigeria’s fast-growing prosperous middle-class and we’re so excited to have partnered to support them.”

About Vista Entertainment Solutions:

Vista Entertainment Solutions Ltd (Vista Cinema) is the world leader in cinema management software solutions with installations in more than 80 countries around the world and an estimated 38% global market share in the Large Cinema Circuit market. The Vista Cinema software product line comprises multiple modules, integrated and scalable, suited to cinema exhibitors operating 20+ screens and 100s of cinemas. Vista Cinema is headquartered in Auckland, New Zealand, and has subsidiaries incorporated in Los Angeles, London, Shanghai, Beijing, Cape Town and Mexico City.

Website: www.vista.co
Twitter: @VistaCinema
LinkedIn: www.linkedin.com/company/vista-entertainment-solutions

About Vista Group International:

Vista Group International (Vista Group) is a public company, listed on both the New Zealand and Australian stock exchanges (NZX & ASX: VGL). The Group provides software and additional technology solutions across the global film industry. Cinema management software is provided by Vista Cinema, the core business of the Group. Movio (authority in moviegoer data analytics), Veezi (cloud-based SaaS software for the Independent Cinema Market), movieXchange (connecting the movie industry to simplify the promotion and sale of movie tickets), Maccs (film distribution software), Numero (box office reporting software for film distributors and cinemas), Cinema Intelligence (business intelligence solutions), Powster (creative studio and marketing platform for movie studios) and Flicks (moviegoer ‘go to’ portal for movie information) provide an innovative range of complementary products across additional film industry sectors, from production and distribution, to cinema exhibition through to the moviegoer experience. Vista Group has offices located in New Zealand (Auckland HQ), Sydney, Los Angeles, London, Shanghai, Beijing, Mexico City, South Africa, the Netherlands and Romania.

Website: www.vistagroup.co
LinkedIn: www.linkedin.com/company/vista-group-limited

About Filmhouse Cinemas:

The Filmhouse Limited is the no. 1 cinema brand in Nigeria and the West African region with a dynamic approach to film exhibition. Filmhouse Cinemas currently has 10 cinemas and is in the process of implementing a strategic development plan to roll-out 15 more within the next two years in West Africa. The company management team has over 100 years’ combined cinema operation and development experience gained in England, USA, Spain and Nigeria. Filmhouse Cinema’s operational style and design largely incorporates complementary, multifarious features, including game arcades, ice cream cafés, food concessions, toy shops, digital cinema, 3D cinema, IMAX format, lounges and kid’s club.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Vista Group International/Auckland, NZ
Christine Fenby
+64 21 727 006
christine.fenby@vista.co
or
Maggie Begley Communications, Los Angeles
Maggie Begley (for Vista Group International)
+1 310-390-0101
maggie@mbcprinc.com
or
Filmhouse Cinemas
Lolu Desalu
+234 (0) 909 532 8599
ldesalu@filmhouseng.com
or
Lanre Aileru
+234 (0) 703 379 6286
laileru@filmhouseng.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kioxia Holdings Corporation Wins IPO of the Year Award in the Equity Category at the DealWatch Awards 202423.5.2025 10:00:00 EEST | Press release

Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced that it had won the IPO of the Year award in the Equity category at the DealWatch Awards 2024, organized by DealWatch, the most authoritative source of real-time intelligence for deal activity within Japan's capital markets. The award was presented at a ceremony held on May 20. The DealWatch Awards recognize outstanding issuers of bonds or equities in the Japanese capital market, as well as Japanese issuers who have conducted offerings overseas, and the securities firms that manage these transactions. The awards for 2024 comprised six categories: Overall, Bonds, Local Government Bonds, Cross-Border Bonds, Sustainable Finance, and Equity. Selection is based on criteria such as the appropriateness of pricing in the issuance market, price formation after transition to the trading market, contribution to the development of capital markets, and innovative efforts, with the awards designed to promot

Generix Named in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS) for the Seventh Consecutive Year23.5.2025 10:00:00 EEST | Press release

Generix, a global business software company offering an expansive portfolio of SaaS solutions for supply chain, finance, commerce, and B2B integration, today announces it has been recognized by Gartner in the 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems (WMS). This is the seventh consecutive year that Generix has been recognized for its portfolio of WMS Solutions. Designed to scale as supply chain operations grow from simple to complex flows, Generix WMS and Solochain WMS are currently in more than 2,000 warehouses globally. “We are honored to be recognized in the Gartner® Magic Quadrant™ WMS for the seventh consecutive year. Generix continues its commitment to providing WMS for every warehousing need at a global scale. With our two recognized WMS solutions, Generix WMS and Solochain WMS, we continue to innovate to better serve customer needs with the introduction of industry game-changing AI use-cases such as resource planning and computer vision,” said Si-Mohamed Sa

NuORDER by Lightspeed and Mandatory Renew Partnership to Power Hybrid Commerce at the Third Edition of the Copenhagen Event23.5.2025 10:00:00 EEST | Press release

Mandatory and NuORDER by Lightspeed, the industry’s leading B2B commerce platform, are joining forces for the third consecutive time to power the digital extension of Mandatory’s in-person trade event, taking place August 5–7 in Copenhagen. This renewed partnership reflects the continued momentum behind hybrid commerce—where physical and digital trade intersect to create smarter, more flexible buying experiences. As the Nordic fashion ecosystem expands with energy and innovation, Mandatory has become a magnet for trendsetting brands and forward-looking retailers. On NuORDER’s wholesale platform, buyer activity from Nordic-region retailers surged by 39.4% year over year in Q1 2025 (January to March). "Retailers in the Nordic region have been quick to adopt digital tools to enhance the efficiency of their buying processes. The increase in buyer activity on the NuORDER platform early this year clearly indicates a growing market demand and a renewed engagement within the industry," said Ch

Curatis discloses Corticorelin as active substance of C-PTBE-0123.5.2025 08:00:00 EEST | Press release

An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute significantly to the quality of life of many patients, combined with the potential of maintaining the efficacy of immunotherapies for these patients, is very motivating and exciting,” said Dr. Roland Rutschmann, Curatis CEO. Key statements Corticorelin (hCRH), a 41 amino acid endogenous polypeptide, has demonstrated the ability to positively impact the blood-brain barrier after a disruption due to the underlying malignant tumor. Curatis intends to develop corticorelin to treat PTBE in primary and metasta

Merck Showcases Innovation in Advanced Cancers and Rare Tumors at ASCO 202523.5.2025 00:43:00 EEST | Press release

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 to June 4 in Chicago. The presentations include the Phase 3 MANEUVER data for potentially best-in-class pimicotinib in the treatment of the rare tumor TGCT, as well as data from both company- and investigator-sponsored studies highlighting the company’s focus on advancing differentiated molecules to tackle some of the most challenging cancers. “The new clinical data we are presenting at ASCO showcase our dedication to advancing innovative therapies for a wide range of diseases—spanning from common cancers to rare non-malignant neoplasms,” said Victoria Zazulina, M.D., Head of Development Unit, Oncology, for the Healthcare business of Merck. “From encouraging early data for our lead antibody-drug conjugate, precemtabart tocentecan, in patients with advanced CRC, to new Phase

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye